These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6153112)

  • 21. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
    Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
    J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide.
    Carreno BM; Turner RV; Biddison WE; Coligan JE
    J Immunol; 1992 Feb; 148(3):894-9. PubMed ID: 1370522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2.
    Gotch F; Rothbard J; Howland K; Townsend A; McMichael A
    Nature; 1987 Apr 30-May 6; 326(6116):881-2. PubMed ID: 2437457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allo-cross-reactivity of a human neuraminidase-specific T cell clone dependent on presentation of an endogenous B cell-specific antigen.
    Kuijpers KC; Treep-Van Leeuwen P; Miedema F; Lucas CJ
    Eur J Immunol; 1991 Jun; 21(6):1453-60. PubMed ID: 1710566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of mutations and variations of HLA-A2 on recognition of a virus peptide epitope by cytotoxic T lymphocytes.
    McMichael AJ; Gotch FM; Santos-Aguado J; Strominger JL
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9194-8. PubMed ID: 2461564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro human cytotoxic T cell responses against influenza A virus can be induced and selected by synthetic peptides.
    Martinon F; Gomard E; Hannoun C; Lévy JP
    Eur J Immunol; 1990 Oct; 20(10):2171-6. PubMed ID: 2242754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defective in vitro production of influenza virus-specific cytotoxic T lymphocytes in ataxia-telangiectasia.
    Nelson DL; Biddison WE; Shaw S
    J Immunol; 1983 Jun; 130(6):2629-34. PubMed ID: 6189897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential Recognition of Influenza A Viruses by M158-66 Epitope-Specific CD8+ T Cells Is Determined by Extraepitopic Amino Acid Residues.
    van de Sandt CE; Kreijtz JH; Geelhoed-Mieras MM; Nieuwkoop NJ; Spronken MI; van de Vijver DA; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    J Virol; 2016 Jan; 90(2):1009-22. PubMed ID: 26537686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens.
    Bjorkman PJ; Saper MA; Samraoui B; Bennett WS; Strominger JL; Wiley DC
    Nature; 1987 Oct 8-14; 329(6139):512-8. PubMed ID: 2443855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Highly conserved pattern of recognition of influenza A wild-type and variant CD8+ CTL epitopes in HLA-A2+ humans and transgenic HLA-A2+/H2 class I-deficient mice.
    Hu N; D'Souza C; Cheung H; Lang H; Cheuk E; Chamberlain JW
    Vaccine; 2005 Nov; 23(45):5231-44. PubMed ID: 16099553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific inhibition of T-cell-mediated cytolosis by alloantiserum against HLA-D-related (DR) antigens.
    Feighery CF; Stastny P
    Transplant Proc; 1979 Mar; 11(1):708-11. PubMed ID: 88098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxic T cell responses in HLA-A2.1 transgenic mice. Recognition of HLA alloantigens and utilization of HLA-A2.1 as a restriction element.
    Le AX; Bernhard EJ; Holterman MJ; Strub S; Parham P; Lacy E; Engelhard VH
    J Immunol; 1989 Feb; 142(4):1366-71. PubMed ID: 2464645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes.
    Bodmer H; Ogg G; Gotch F; McMichael A
    Nature; 1989 Nov; 342(6248):443-6. PubMed ID: 2479838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro influenza virus-specific antibody production in man: antigen-specific and HLA-restricted induction of helper activity mediated by cloned human T lymphocytes.
    Lamb JR; Woody JN; Hartzman RJ; Eckels DD
    J Immunol; 1982 Oct; 129(4):1465-70. PubMed ID: 6180010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in the alpha 2 helix of HLA-A2 affect presentation but do not inhibit binding of influenza virus matrix peptide.
    Hogan KT; Shimojo N; Walk SF; Engelhard VH; Maloy WL; Coligan JE; Biddison WE
    J Exp Med; 1988 Aug; 168(2):725-36. PubMed ID: 3261776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The loss of immunodominant epitopes affects interferon-gamma production and lytic activity of the human influenza virus-specific cytotoxic T lymphocyte response in vitro.
    Berkhoff EG; Geelhoed-Mieras MM; Verschuren EJ; van Baalen CA; Gruters RA; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    Clin Exp Immunol; 2007 May; 148(2):296-306. PubMed ID: 17326762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct recognition of influenza virus hemagglutinin and H-2 antigens by cytotoxic thymus derived lymphocytes.
    Ennis FA; Martin WJ; Verbonitz MW
    Dev Biol Stand; 1977 Jun 1-3; 39():373-8. PubMed ID: 304819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design.
    Altfeld M; Allen TM; Kalife ET; Frahm N; Addo MM; Mothe BR; Rathod A; Reyor LL; Harlow J; Yu XG; Perkins B; Robinson LK; Sidney J; Alter G; Lichterfeld M; Sette A; Rosenberg ES; Goulder PJ; Brander C; Walker BD
    J Virol; 2005 Apr; 79(8):5000-5. PubMed ID: 15795285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unusual restriction of a proliferative line reacting with influenza A and B viruses.
    Sterkers G; Hannoun C; Levy JP
    Immunogenetics; 1983; 17(3):271-81. PubMed ID: 6601052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
    Strang G; Rickinson AB
    Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.